Loading…
Based on limited metadata, OHM Pharma, Inc. received an FDA Warning Letter on November 19, 2019, regarding dietary supplements. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The warning relates to FDA's dietary supplement regulatory authority, though the specific issuing office and violation details are not provided in this metadata.